Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 5801 - 5825 of 6954 in total

6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid

Experimental

N1-CYCLOPENTYL-N2-(THIAZOL-2-YL)OXALAMIDE

Experimental

Autologous DNP-conjugated tumour vaccine

Autologous DNP-conjugated tumour vaccine, or melanoma vaccine, is an investigational autologous cell vaccine technology for melanoma.
Investigational

Polyvalent antigen-KLH conjugate vaccine

Polyvalent antigen-KLH conjugate vaccine is a multivalent cancer vaccine comprised of the five tumor-associated antigens (TAAs) globo H, GM2 ganglioside, Tn-MUC1, TF, and sTn conjugated with the immunoadjuvant keyhole limpet hemocyanin (KLH). It is under investigation in clinical trial NCT01223235 (Polyvalent Vaccine-klh Conjugate + Opt-821 Given in Combination With Bevacizumab).
Investigational

JQ1

First-in-class potent and selective inhibitor of the BRD4 signaling pathway.
Investigational

Oxothiazolidinecarboxylic acid

Procysteine has been used in trials studying the treatment of HIV Infections.
Investigational

Ifinatamab deruxtecan

Investigational

Robalzotan

Investigational

Ad5-nCoV

Ad5-nCoV is a recombinant adenovirus type-5 vector (Ad5) vaccine currently being investigated for prophylaxis against SARS-CoV-2.[L12675,L12678] It is being developed by CanSino Biologics Inc., in partnership with the Beijing Institute of Biotechnology, who in March 2020 announced the approval of a phase I clinical trial (ChiCTR2000030906) with an expected completion...
Investigational

9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE

Experimental

Tilavonemab

Investigational

Zafiride

Zafiride is a human tumor necrosis factor coupled to the C terminus of CNGRCG peptide.
Investigational
Matched Description: … Zafiride is a human tumor necrosis factor coupled to the C terminus of CNGRCG peptide. …

Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide

Experimental

2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE

Experimental
Matched Name: … 2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE …
Matched Iupac: … 2-[4-(aminomethyl)piperidin-1-yl]-N-{3-cyclohexyl-4-oxo-2H,4H-indeno[1,2-c]pyrazol-5-yl}acetamide …

N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide

Experimental

3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID

Experimental

N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3

Experimental

alpha-N-Acetyl-D-galactosamine

The N-acetyl derivative of galactosamine. [PubChem]
Experimental
Investigational

S-(N-hydroxy-N-bromophenylcarbamoyl)glutathione

Experimental

Zinpentraxin alfa

Zinpentraxin alfa is a recombinant form of PTX-2, a naturally circulating human protein. It is under investigation in clinical trial NCT01981850 (A Phase 2 Study Of PRM-151 In Subjects With Myelofibrosis).
Investigational

Ontamalimab

Ontamalimab is under investigation in clinical trial NCT03627091 (Efficacy and Safety Study of SHP647 as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)).
Investigational

Enapotamab vedotin

Enapotamab vedotin is under investigation in clinical trial NCT02988817 (Enapotamab Vedotin (Humax-axl-adc) Safety Study in Patients With Solid Tumors).
Investigational

Mirvetuximab

Investigational

Senaparib

Investigational

Algenpantucel-L

Investigational
Displaying drugs 5801 - 5825 of 6954 in total